...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Gradient of dopamine responsiveness to dopamine receptor agonists in subregions of the rat nucleus accumbens.
【24h】

Gradient of dopamine responsiveness to dopamine receptor agonists in subregions of the rat nucleus accumbens.

机译:在大鼠伏隔核子区域中多巴胺对多巴胺受体激动剂的响应梯度。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study sought to investigate the possibility that the degree of selectivity of dopamine D3/D2 receptor agonists such as quinelorane, 7-hydroxy-2-dipropylaminotetralin (7-OH-DPAT), quinpirole and apomorphine on dopamine D3 over D2 receptor subtypes can be assessed by measuring dopamine transmission in the shell vs. core compartments of the nucleus accumbens by using microdialysis in freely moving rats. Significant reductions in dialysate dopamine levels compared to vehicle-treated animals were observed in the shell of the nucleus accumbens with 3, 10 and 30 microg/kg quinelorane, 100 microg/kg 7-OH DPAT, 25 and 100 microg/kg quinpirole, and 100 microg/kg apomorphine. In the core subregion, significant reductions in dopamine were seen at 10 and 30 microg/kg quinelorane, 25 and 100 microg/kg 7-OH-DPAT, 100 microg/kg quinpirole and 100 microg/kg apomorphine. However, a significant shell/core dichotomy could only be observed in response to the lowest dose of quinelorane (3 microg/kg) with the shell being hyper-responsive compared with the core. The present findings suggest that quinelorane is one of the most selective dopamine D3 receptor agonists based on its ability to target the shell subregion of the nucleus accumbens.
机译:本研究试图调查多巴胺D3 / D2受体激动剂(例如喹诺洛烷,7-羟基-2-二丙基氨基四氢萘(7-OH-DPAT),喹吡罗和阿扑吗啡)对多巴胺D3的选择性程度是否超过D2受体亚型的可能性。通过在自由移动的大鼠中使用微透析法,通过测量伏隔核的壳与核室中的多巴胺传递来评估。与含媒介物的动物相比,在伏隔核的壳中观察到透析液多巴胺水平显着降低,其中伏安核的壳中含3、10和30微克/千克喹啉,100微克/千克7-OH DPAT,25和100微克/千克喹吡罗,以及100微克/千克阿扑吗啡。在核心分区域,在10和30 microg / kg喹啉,25和100 microg / kg 7-OH-DPAT,100 microg / kg喹吡罗和100 microg / kg阿扑吗啡下,多巴胺显着减少。但是,仅在对最低剂量的喹啉烷(3 microg / kg)作出反应时才能观察到明显的壳/核二分法,而与核相比,壳具有高反应性。目前的发现表明,喹诺罗烷是靶向伏隔核壳部分的能力最强的多巴胺D3受体激动剂之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号